共 31 条
[2]
Pointstoconsideronclinicalinvestigationofmedicinalproductsforprophylaxisofintra-andpostoperativevenousthromboembolicrisk. CommitteeforProprietaryMedicinalProducts. . 2000
[3]
Earlypostoperativemor-talityafter67,548totalhipreplacements:causesofdeathandthrom-boprophylaxisin68hospitalsinNorwayfrom1987to1999. LieSA,,EngesaeterLB,HavelinLI,etal. Acta Orthopaedica Scandinavica . 2002
[4]
Mortalityaftertotalhipreplacement:0-10-yearfollow-upof39,543patientsintheNorwe-gianArthroplastyRegister. LieSA,,EngesaeterLB,HavelinLI,etal. Acta Orthopaedica Scandinavica . 2000
[5]
Costofvenousthromboem-bolismfollowingmajororthopedicsurgeryinhospitalizedpatients. OllendorfDA,,Vera-LlonchM,OsterG. AmJHealthSystPharm . 2002
[8]
Thecost-effectivenessoffon-daparinuxcomparedwithenoxaparinasprophylaxisagainstthrom-boembolismfollowingmajororthopedicsurgery. GordoisA,,PosnettJ,BorrisL,etal. JThrombHaemost . 2003
[9]
Preventionofvenousthrom-boembolism:theSeventhACCPConferenceonAntithromboticandThrombolyticTherapy. GeertsWH,,PineoGF,HeitJA,etal. Chest . 2004